Suchergebnisse - "Massonnaud, Clément R"

PubPharm (7)

1

Recombinant Influenza Vaccine in Adults under 65 Years of Age

enthalten in: The New England journal of medicine | 2024

von Haviari, S. | Massonnaud, C. | Dupont, A.

CommentOn: N Engl J Med. 2023 Dec 14;389(24):2245-2255. - PMID 38091531

2

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy) : A phase 3, randomized, double-blind, placebo-controlled trial

enthalten in: The Journal of infection | 2024

von Hites, M. | Lapique, E. | Massonnaud, C. | +84

3

Modeling the impact of national and regional lockdowns on the 2020 spring wave of COVID-19 in France

enthalten in: Scientific reports | 2023

von Roux, J. | Massonnaud, C. | Colizza, V. | +2

4

Evaluating COVID-19 booster vaccination strategies in a partially vaccinated population: a modeling study

enthalten in: bioRxiv.org | 2022

von Massonnaud, C. | Roux, J. | Colizza, V. | +1

5

Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population : A Modeling Study

enthalten in: Vaccines | 2022

von Massonnaud, C. | Roux, J. | Colizza, V. | +1

6

A modelling study investigating short and medium-term challenges for COVID-19 vaccination : From prioritisation to the relaxation of measures

enthalten in: EClinicalMedicine | 2021

von Tran Kiem, C. | Massonnaud, C. | Levy-Bruhl, D. | +10

7

Identification of the Best Semantic Expansion to Query PubMed Through Automatic Performance Assessment of Four Search Strategies on All Medical Subject Heading Descriptors : Comparative Study

enthalten in: JMIR medical informatics | 2020

von Massonnaud, C. | Kerdelhué, G. | Grosjean, J. | +3

1
[1]